BioSyent Inc. (BIOYF)

BioSyent Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	4.91	7.86	18.04	20.29	13.44
Short-Term Investments	21.28	20.83	10.18	5.29	8.53
Cash & Cash Equivalents	26.19	28.7	28.21	25.58	21.97
Cash Growth	-8.74%	1.72%	10.30%	16.40%	-10.04%
Receivables	3.55	3.66	3.21	1.82	2.08
Inventory	5.89	4.54	2.2	2.07	2.14
Other Current Assets	0.24	0.25	0.46	0.31	0.65
Total Current Assets	35.87	37.14	34.08	29.77	26.85
Property, Plant & Equipment	1.44	1.67	1.93	2.16	2.48
Long-Term Investments	2.71	0.26	0.18	0.6	0.59
Intangible Assets	1.15	1.2	0.87	1.01	1.02
Other Long-Term Assets	0.36	0.21	0.1	0.03	0.03
Total Long-Term Assets	5.66	3.34	3.09	3.8	4.12
Total Assets	41.53	40.49	37.17	33.57	30.97
Accounts Payable	5.08	5.06	3.56	3.72	2.92
Deferred Revenue	0.13	0.16	0.31	0.93	0.1
Current Debt	0.18	0.17	0.16	0.15	0.14
Other Current Liabilities	0.14	0.32	0.1	0.33	0.2
Total Current Liabilities	5.53	5.72	4.14	5.14	3.36
Long-Term Debt	1.04	1.22	1.4	1.56	1.71
Other Long-Term Liabilities	0.2	0.18	0.08	0.08	0.1
Total Long-Term Liabilities	1.24	1.4	1.48	1.64	1.81
Total Liabilities	6.77	7.12	5.61	6.78	5.17
Total Debt	1.22	1.4	1.56	1.71	1.85
Debt Growth	-12.48%	-10.39%	-8.89%	-7.78%	-
Common Stock	5.12	5.37	5.8	6.39	7.18
Retained Earnings	27.53	25.91	24.12	19.08	17.48
Comprehensive Income	-0.18	-0.14	-0.19	-0.17	-0.11
Shareholders' Equity	34.76	33.36	31.55	26.8	25.79
Total Liabilities and Equity	41.53	40.49	37.17	33.57	30.97
Net Cash / Debt	24.97	27.3	26.65	23.87	20.12
Net Cash / Debt Growth	-8.55%	2.42%	11.67%	18.63%	-17.62%
Net Cash Per Share	2.05	2.18	2.07	1.82	1.44
Working Capital	30.34	31.42	29.94	24.64	23.49
Book Value Per Share	2.91	2.71	2.49	2.06	1.85

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.